| Literature DB >> 28642656 |
David Sadigursky1, Daniel Pereira Simões1, Raphael Araújo de Albuquerque1, Monize Zórnio Silva2, Rogério Jamil Carneiro Fernandes1, Paulo Oliveira Colavolpe1.
Abstract
OBJECTIVE: To evaluate the use of infiltration of periarticular analgesic agents intraoperatively in total knee arthroplasty (TKA), with regard to benefits, reduction of pain, opioid consumption, improvement of range of motion and early ambulation.Entities:
Keywords: Analgesia; Arthroplasty; Knee; Seepage
Year: 2017 PMID: 28642656 PMCID: PMC5474418 DOI: 10.1590/1413-785220172502151116
Source DB: PubMed Journal: Acta Ortop Bras ISSN: 1413-7852 Impact factor: 0.513
Multimodal drugs used for periarticular knee infiltration.
| Bupivacaine 0.5% | 400 mg/20ml |
| Epinephrine 1/1000 | 1/1000 (0.3ml) 300 Mcg |
| Triamcinolone hexacetonide | 20mg/1ml |
| Clonidine | 150mcg/1ml |
| Saline solution (0.9%) | 20ml |
Clinical data for patients undergoing TKA from 2008 to 2014.
| Characteristic | Total (n = 59) | Without infiltration (n = 30) | Periarticular injection (n = 29) |
|---|---|---|---|
| Side affected | |||
| Right | 30.0 (50.8) | 16.0 (53.3) | 14.0 (48.3) |
| Left | 29.0 (49.0) | 14.0 (46.7) | 15.0 (51.7) |
| Comorbidities | |||
| High blood pressure (HBP) | 30.0 (50.8) | 13.0 (43.3) | 17.0 (58.6) |
| Diabetes mellitus | 10.0 (16.9) | 3.0 (10.0) | 7.0 (24.1) |
| Dyslipidemia | 5.0 (8.5) | 2.0 (6.7) | 3.0 (10.3) |
| Controlled Chronic Kidney Disease | 2.0 (3.4) | 1.0 (3.3) | 1.0 (3.4) |
| Previous Stroke | 2.0 (3.4) | 2.0 (6.7) | 0.0 (0.0) |
| Gastroesophageal Reflux Disease | 1.0 (1.7) | 1.0 (1.6) | 0.0 (0.0) |
All data are presented as n (%).
Data relating to surgery for groups of patients undergoing TKA from 2008 to 2014.
| Visual analog Pain scale | Total (n = 59) | Without infiltration (n = 30) | Periarticular injection (n = 29) | p value |
|---|---|---|---|---|
| (Mean ± Standard deviation) | ||||
| Preoperative | 7.9 ± 0.8 | 7.7 ± 0.6 | 8.1 ± 0.9 | 0.065 |
| 24h Postoperative | 4.5 ± 1.2 | 5.3 ± 0.9 | 3.7 ± 0.9 | < 0.001 |
| 48h Postoperative | 4.3 ± 1.2 | 4.8 ± 1.1 | 3.9 ± 1.2 | 0.004 |
| Functional Capacity | ||||
| WOMAC (Mean ± Standard deviation) | ||||
| Preoperative | 28.6 ± 7.1 | 26.0 ± 5.2 | 31.2 ± 7.9 | 0.004 |
| Postoperative (3 months) | 47.3 ± 7.0 | 47.1 ± 6.6 | 47.4 ± 7.5 | 0.865 |
| Rescue opioid | ||||
| 24h | 150.0 (100.0 - 300.0) | 200 (100.0 - 300.0) | 150.0 (100.0 - 200.0) | 0.123 |
| 48h | 100 (50.0 - 150.0) | 150 (100.0 - 200.0) | 50 (0.0 - 100.0) | < 0.001 |
| Complications | ||||
| Nausea | 9.0 (15.3) | 6.0 (20.0) | 3.0 (10.3) | 0.472 |
| Vomiting | 5.0 (8.5) | 4.0 (13.3) | 1.0 (3.4) | 0.353 |
| Headache | 4.0 (6.8) | 4.0 (13.3) | 0.0 (0.0) | 0.112 |
| Incontinence | 2.0 (3.4) | 0.0 (0.0) | 2.0 (6.9) | 0.237 |
| Range of motion | ||||
| Preoperative (medians, extension - flexion) | 0 - 120 | 0 - 120 | 0 - 120 | |
| Postoperative (medians, extension - flexion) | 0 - 100 | 0 - 100 | 0 - 110 |
a - Student's t test; b - Chi-squared test; c - Mann-Whitney U test; d - Fisher's exact test.
Estimated means according to the ANCOVA model.
| Visual analog pain scale | Without infiltration (n = 30) | Periarticular injection (n = 29) |
|---|---|---|
| (Mean ± Standard deviation) | ||
| Preoperative | 7,8 ± 0,1 (7,5 - 8,1) | 8,1 ± 0,2 (7,7 - 8,4) |
| 24h Postoperative | 5,3 ± 0,2 (4,9 - 5,7) | 3,7 ± 0,2 (3,3 - 4,1) |
| 48h Postoperative | 4,8 ± 0,2 (4,3 - 5,3) | 3,7 ± 0,2 (3,3 - 4,3) |
Notes: a - Controlling for preoperative WOMAC and rescue opioid in 48 hours; All values are presented as mean ± standard deviation (95% confidence interval). MPA = Multimodal Periarticular Analgesia.
Figure 1Mean values for VAS pre and postoperative estimated from ANCOVA of repeated measurements from patients who underwent TKA at the Clínica Ortopédica e Traumatológica in Salvador, Bahia from 2008 to 2014.